---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-130966"
form_type: "8-K"
ticker: "CTSO"
cik: "0001175151"
company_name: "Cytosorbents Corp"
filed_at: "2022-12-29T23:59:59+00:00"
generated_at: "2026-06-20T21:47:42.377526+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# CytoSorbents draws $5M debt from Bridge Bank, extends $10M drawdown to March 2023

## Summary
- Received $5M non-dilutive term loan; no financial covenants on initial tranche.
- Drawdown period for remaining $10M extended from Dec 31, 2022 to March 1, 2023.
- Loan at Index Rate +1.25% (min 3.25%), capped at 8%; interest-only until Jan 2024, principal+interest to Dec 2025.
- Funds to support U.S. STAR-T pivotal trial for DrugSorb-ATR™, commercial growth, and cost control.

## SEC filing metadata
- accession: 0001104659-22-130966
- form_type: 8-K
- ticker: CTSO
- cik: 0001175151
- company_name: Cytosorbents Corp
- filed_at: 2022-12-29T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1175151/000110465922130966/0001104659-22-130966-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1175151/000110465922130966/tm2233609d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-130966
- JSON: https://secwatch.observer/filing/0001104659-22-130966.json
- Plain text: https://secwatch.observer/filing/0001104659-22-130966.txt

## Key facts
- Material Agreements
  Cytosorbents Corp amended Fifth Amendment with Bridge Bank valued at $10 million (effective 2022-12-28).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: Bridge Bank
  - Value: $10 million
  - Effective: 2022-12-28
  source text: On December 28, 2022 (the “ Fifth Amendment Date ”), CytoSorbents Corporation, a Delaware corporation (the “ Company ”), CytoSorbents Medical, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ CytoSorbents Medical ” and, together with the Company, the “ Borrower ”) and Bridge Bank, a division of Western Alliance Bank, an Arizona corporation (the “ Bank ”), entered into an amendment (the “ Fifth Amendment ”) to that certain Amended and Restated Loan and Security Agreement
  evidence_url: https://www.sec.gov/Archives/edgar/data/1175151/000110465922130966/0001104659-22-130966-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.